<img src="https://ml.globenewswire.com/Resource/Download/bff1e728-30ed-46c6-81e1-8bbc795929c0?size=2" nborder="0" align="left" hspace="5" vspace="5" title="01_PrimaryLogo_Color_BlueX-100.jpg" alt="Praxis Precision Medicines, Inc."/>BOSTON, June 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=_kcvXLmzZYfJ_cQTmaNQWB8pKLq2RGx7j3CKuKZFc-JDYnVbovbcApF1OO1CmgG1udP8-AaU7DU1rkLWas_PMLnnJmVYqXY21Nmwg8pQqzDMgAGMm-3-TDez8Qgy-NGV" rel="nofollow" target="_blank" title="Praxis Precision Medicines">Praxis Precision Medicines</a>, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it will be presenting a corporate overview at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 taking place in Miami, FL at the Loews Miami Beach Hotel on Monday, June 8, 2026 at 8:00am ET. A live webcast of the event will be available through this <a href="https://www.globenewswire.com/Tracker?data=qAFij8DqpEzmZ-vZrHV51hBP1-3FjqndeLBkMtnDvNrUKQxaEmwvq71o1i9EOGRJiTolelGabfAusOyA1LxBol51tudJoDtjoQepWgaHEXrJxW7QsuV_AYW0zzdQjP0R" rel="nofollow" target="_blank" title="link">link</a>. A replay of the event will also be available on Praxis’ “<a href="https://www.globenewswire.com/Tracker?data=X8JfuWrAavIpvxxus0b-Ql1dZ2Me_4aaJzGNKMjNNT1LP5iq85a6_OQfr1rfKtLw91m4qztQLfpS2b1v7V43XndfPIYTXShhQIkbNiiaZlJ-1_VjH_Sj64xFYrBBJX7ssfIfM39dKFTAmkX7FRa4kbEf21hpeN_JSKbkddk5moA=" rel="nofollow" target="_blank" title="Events and Presentations">Events and Presentations</a>” website after each event for approximately 180 days. About Praxis   Praxis Precision Medicines is a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum™, and antisense oligonucleotide (ASO) platform, Solidus™, using our understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across movement disorders and epilepsy, with four late-stage product candidates. For more information, please visit <a href="https://www.globenewswire.com/Tracker?data=RrslqkZgB2AFPIhEwi803gsm5JnIM0sBJdoF2hfPfRZUaKsUGgSAjUn8DnMv4zo7g3W6dDugTEoUZRNb97MnLV2Ze5HMNhY-fRSqy_bcomWgtgFalFMVtXQHT5Mlixom4Tmripba-cAJSaJSeWmn0uVAYOiVztX6zst1ZFJA9TDlipS8xgMd_yrUJceNDH3FHTT1ObGf7IIRD7hUB7ahkhjSYctn0uPvHb8xpJpOXwnBlLIX1rZB0C85jKk7j_FxuFC8aQ40Co6OTVMEpfU9g2iqKhATugd0WhfLJA78Sac=" rel="nofollow" target="_blank" title="www.praxismedicines.com">www.praxismedicines.com</a> and follow us on <a href="https://www.globenewswire.com/Tracker?data=-XMEXKOOnvoY69__ThhSkJ5r4lXSYsee3LDziZTMjk7VCURR3hs40ZK7VmWatmDulW34EdkJbAFM97vnVZKRJEdPdPQJWmbfB8fHEj_l-0RScjGFhOBS7dK_ueojUbdt" rel="nofollow" target="_blank" title="Facebook">Facebook</a><a href="https://www.globenewswire.com/Tracker?data=S5A36_cWSzQ_hNkYkYMgjU_pgm543HF2Y1rcwBl3pbslXu-dgkXze_8oQ9eVI5KA34HCLWefEWkvbezW8ocfcQ1Gx-fdzSZJ1y0tsOmG1qw=" rel="nofollow" target="_blank" title=",">,</a> LinkedIn and <a href="https://www.globenewswire.com/Tracker?data=-9wZO48jcXe5BCLNsij6Sb77nubmlsiqdktGnwGN0_6mW8T-6Ztjwz6PxYKu-Gbm9oHtdDTUGDqCE0pTuxzftpVB15TH86WDWT6Cf67PNEA=" rel="nofollow" target="_blank" title="X/Twitter">X/Twitter</a>. <pre>CONTACT: Investor Contact: 
Praxis Precision Medicines 
investors@praxismedicines.com 
857-702-9452 
 
Media Contact:
Dan Ferry
LifeSci Advisors
Daniel@lifesciadvisors.com
617-430-7576</pre> <img alt="" src='https://ml.globenewswire.com/media/M2FiOGU4NTYtMjM1NC00MDA4LWE0N2YtZTM0ZTAxZTkzMDAyLTEyMTI0NDktMjAyNi0wNi0wNC1lbg==/tiny/Praxis-Precision-Medicines-Inc.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn